6 research outputs found
Brute-Force Hyperpolarization for NMR and MRI
Hyperpolarization (HP) of nuclear
spins is critical for ultrasensitive
nuclear magnetic resonance (NMR) and magnetic resonance imaging (MRI).
We demonstrate an approach for >1500-fold enhancement of key small-molecule
metabolites: 1-<sup>13</sup>C-pyruvic acid, 1-<sup>13</sup>C-sodium
lactate, and 1-<sup>13</sup>C-acetic acid. The <sup>13</sup>C solution
NMR signal of pyruvic acid was enhanced 1600-fold at <i>B</i> = 1 T and 40 Ā°C by pre-polarizing at 14 T and ā¼2.3 K.
This ābrute-forceā approach uses only field and temperature
to generate HP. The noted 1 T observation field is appropriate for
benchtop NMR and near the typical 1.5 T of MRI, whereas high-field
observation scales enhancement as 1/<i>B</i>. Our brute-force
process ejects the frozen, solid sample from the low-<i>T</i>, high-<i>B</i> polarizer, passing it through low field
(<i>B</i> < 100 G) to facilitate āthermal mixingā.
That equilibrates <sup>1</sup>H and <sup>13</sup>C in hundreds of
milliseconds, providing <sup>13</sup>C HP from <sup>1</sup>H Boltzmann
polarization attained at high <i>B</i>/<i>T</i>. The ejected sample arrives at a room-temperature, permanent magnet
array, where rapid dissolution with 40 Ā°C water yields HP solute.
Transfer to a 1 T NMR system yields <sup>13</sup>C signals with enhancements
at 80% of ideal for noted polarizing conditions. High-resolution NMR
of the same product at 9.4 T had consistent enhancement plus resolution
of <sup>13</sup>C shifts and <i>J</i>-couplings for pyruvic
acid and its hydrate. Comparable HP was achieved with frozen aqueous
lactate, plus notable enhancement of acetic acid, demonstrating broader
applicability for small-molecule NMR and metabolic MRI. Brute-force
avoids co-solvated free-radicals and microwaves that are essential
to competing methods. Here, unadulterated samples obviate concerns
about downstream purity and also exhibit slow solid-state spin relaxation,
favorable for transporting HP samples
Dynamic Nuclear Polarization Enhanced Natural Abundance <sup>17</sup>O Spectroscopy
We show that natural abundance oxygen-17 NMR of solids
could be
obtained in minutes at a moderate magnetic field strength by using
dynamic nuclear polarization (DNP). Electron spin polarization could
be transferred either directly to <sup>17</sup>O spins or indirectly
via <sup>1</sup>H spins in inorganic oxides and hydroxides using an
oxygen-free solution containing a biradical polarization agent (bTbK).
The results open up a powerful method for rapidly acquiring high signal-to-noise
ratio solid-state NMR spectra of <sup>17</sup>O nuclear spins and
to probe sites on or near the surface, without the need for isotope
labeling
Dynamic Nuclear Polarization Study of Inhibitor Binding to the M2<sub>18ā60</sub> Proton Transporter from Influenza A
We demonstrate the use of dynamic
nuclear polarization (DNP) to
elucidate ligand binding to a membrane protein using dipolar recoupling
magic angle spinning (MAS) NMR. In particular, we detect drug binding
in the proton transporter M2<sub>18ā60</sub> from influenza
A using recoupling experiments at room temperature and with cryogenic
DNP. The results indicate that the pore binding site of rimantadine
is correlated with previously reported widespread chemical shift changes,
suggesting functional binding in the pore. Futhermore, the <sup>15</sup>N-labeled ammonium of rimantadine was observed near A30 <sup>13</sup>CĪ² and G34 <sup>13</sup>CĪ±, suggesting a possible hydrogen
bond to A30 carbonyl. Cryogenic DNP was required to observe the weaker
external binding site(s) in a ZF-TEDOR spectrum. This approach is
generally applicable, particularly for weakly bound ligands, in which
case the application of MAS NMR dipolar recoupling requires the low
temperatures to quench dynamic exchange processes. For the fully protonated
samples investigated, we observed DNP signal enhancements of ā¼10
at 400 MHz using only 4ā6 mM of the polarizing agent TOTAPOL.
At 600 MHz and with DNP, we measured a distance between the drug and
the protein to a precision of 0.2 Ć
Atomic Resolution Structure of Monomorphic AĪ²<sub>42</sub> Amyloid Fibrils
Amyloid-Ī²
(AĪ²) is a 39ā42 residue protein produced
by the cleavage of the amyloid precursor protein (APP), which subsequently
aggregates to form cross-Ī² amyloid fibrils that are a hallmark
of Alzheimerās disease (AD). The most prominent forms of AĪ²
are AĪ²<sub>1ā40</sub> and AĪ²<sub>1ā42</sub>, which differ by two amino acids (I and A) at the C-terminus. However,
AĪ²<sub>42</sub> is more neurotoxic and essential to the etiology
of AD. Here, we present an atomic resolution structure of a monomorphic
form of AĪ²<sub>M01ā42</sub> amyloid fibrils derived from
over 500 <sup>13</sup>Cā<sup>13</sup>C, <sup>13</sup>Cā<sup>15</sup>N distance and backbone angle structural constraints obtained
from high field magic angle spinning NMR spectra. The structure (PDB
ID: 5KK3) shows
that the fibril core consists of a dimer of AĪ²<sub>42</sub> molecules,
each containing four Ī²-strands in a S-shaped amyloid fold, and
arranged in a manner that generates two hydrophobic cores that are
capped at the end of the chain by a salt bridge. The outer surface
of the monomers presents hydrophilic side chains to the solvent. The
interface between the monomers of the dimer shows clear contacts between
M35 of one molecule and L17 and Q15 of the second. Intermolecular <sup>13</sup>Cā<sup>15</sup>N constraints demonstrate that the
amyloid fibrils are parallel in register. The RMSD of the backbone
structure (Q15āA42) is 0.71 Ā± 0.12 Ć
and of all heavy
atoms is 1.07 Ā± 0.08 Ć
. The structure provides a point of
departure for the design of drugs that bind to the fibril surface
and therefore interfere with secondary nucleation and for other therapeutic
approaches to mitigate AĪ²<sub>42</sub> aggregation
Cysteine-Specific Labeling of Proteins with a Nitroxide Biradical for Dynamic Nuclear Polarization NMR
Dynamic
nuclear polarization (DNP) enhances the signal in solid-state
NMR of proteins by transferring polarization from electronic spins
to the nuclear spins of interest. Typically, both the protein and
an exogenous source of electronic spins, such as a biradical, are
either codissolved or suspended and then frozen in a glycerol/water
glassy matrix to achieve a homogeneous distribution. While the use
of such a matrix protects the protein upon freezing, it also reduces
the available sample volume (by ca. a factor of 4 in our experiments)
and causes proportional NMR signal loss. Here we demonstrate an alternative
approach that does not rely on dispersing the DNP agent in a glassy
matrix. We synthesize a new biradical, ToSMTSL, which is based on
the known DNP agent TOTAPOL, but also contains a thiol-specific methanethiosulfonate
group to allow for incorporating this biradical into a protein in
a site-directed manner. ToSMTSL was characterized by EPR and tested
for DNP of a heptahelical transmembrane protein, <i>Anabaena</i> sensory rhodopsin (ASR), by covalent modification of solvent-exposed
cysteine residues in two <sup>15</sup>N-labeled ASR mutants. DNP enhancements
were measured at 400 MHz/263 GHz NMR/EPR frequencies for a series
of samples prepared in deuterated and protonated buffers and with
varied biradical/protein ratios. While the maximum DNP enhancement
of 15 obtained in these samples is comparable to that observed for
an ASR sample cosuspended with ā¼17 mM TOTAPOL in a glycerol-<i>d</i><sub>8</sub>/D<sub>2</sub>O/H<sub>2</sub>O matrix, the
achievable sensitivity would be 4-fold greater due to the gain in
the filling factor. We anticipate that the DNP enhancements could
be further improved by optimizing the biradical structure. The use
of covalently attached biradicals would broaden the applicability
of DNP NMR to structural studies of proteins
Higher Order Amyloid Fibril Structure by MAS NMR and DNP Spectroscopy
Protein magic angle spinning (MAS)
NMR spectroscopy has generated
structural models of several amyloid fibril systems, thus providing
valuable information regarding the forces and interactions that confer
the extraordinary stability of the amyloid architecture. Despite these
advances, however, obtaining atomic resolution information describing
the higher levels of structural organization within the fibrils remains
a significant challenge. Here, we detail MAS NMR experiments and sample
labeling schemes designed specifically to probe such higher order
amyloid structure, and we have applied them to the fibrils formed
by an eleven-residue segment of the amyloidogenic protein transthyretin
(TTR(105ā115)). These experiments have allowed us to define
unambiguously not only the arrangement of the peptide Ī²-strands
into Ī²-sheets but also the Ī²-sheet interfaces within each
protofilament, and in addition to identify the nature of the protofilament-to-protofilament
contacts that lead to the formation of the complete fibril. Our efforts
have resulted in 111 quantitative distance and torsion angle restraints
(10 per residue) that describe the various levels of structure organization.
The experiments benefited extensively from the use of dynamic nuclear
polarization (DNP), which in some cases allowed us to shorten the
data acquisition time from days to hours and to improve significantly
the signal-to-noise ratios of the spectra. The Ī²-sheet interface
and protofilament interactions identified here revealed local variations
in the structure that result in multiple peaks for the exposed N-
and C-termini of the peptide and in inhomogeneous line-broadening
for the residues buried within the interior of the fibrils